Drugs News and Research

RSS

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Obstetrics, Gynaecology & Women's Health shows that, following a review and meta-analysis of available studies, use of glucagon-like peptide-1 receptor agonists (GLP-1 RA) drugs for diabetes and weight management in women living with diabetes is not associated with adverse pregnancy outcomes in most cases.

1 Oct 2026

Study examines the real-world use of GLP-1 RA drugs in children and young people

New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) has examined the real-world use of GLP-1 receptor agonist (GLP-1 RA) drugs in children and young people in Germany, Austria and Luxembourg.

30 Sep 2026

Insurance hurdles and costs hinder access to blood cancer drugs

Patients with blood cancers often face major insurance hurdles and significant out-of-pocket costs when trying to access specialty oral anticancer medications, according to a new nationwide study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.

30 Sep 2026

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Researchers from University of California San Diego have received a $12.6 million award from the National Institute on Drug Abuse (NIDA) to establish the Polysubstance Addiction Research Center (PARC), a multidisciplinary center designed to uncover the biological factors that contribute to addiction across multiple substances.

30 Sep 2026

Scientists discover molecular pathway that controls cellular waste recycling

For years, TFEB has been regarded as one of the most promising therapeutic targets for restoring the cell's ability to clear and recycle waste.

30 Sep 2026

MSU researchers seek to better understand a viral mechanism shared between influenza and HIV

When you get your yearly flu shot, you're helping your body stay one step ahead of the rapidly mutating influenza virus. But what if there was a way to achieve stronger, multi-year protection from a single jab?

30 Sep 2026

Declining benzodiazepine use reflects more cautious medical prescribing practices

The number of benzodiazepine prescriptions like Xanax and Valium dispensed in the United States decreased over the past 10 years, potentially suggesting that doctors have become more cautious when prescribing these sedatives, according to Rutgers Health researchers.

30 Sep 2026

Anti-fibrotic compound alters cell communication by redirecting cellular packages

An experimental anti-fibrotic compound can dramatically alter how cells release the microscopic packages they use to communicate, according to new research from the University of Surrey.

30 Sep 2026

Streamlining CRISPR workflows, from editing to analysis

INTEGRA's automated solutions optimize CRISPR workflows, enhancing gene editing efficiency and accelerating the path to innovative therapeutic developments.

From INTEGRA Biosciences 30 Sep 2026

Petrelintide produces double-digit weight loss with fewer side effects

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) and published in The Lancet Diabetes & Endocrinology shows that weekly injections with the new amylin-based obesity drug petrelintide can enable those treated to lose more than 10% of their body weight – generally lower than existing incretin-based (GLP-1 RA) drugs, but also with far fewer side effects.

29 Sep 2026

$5.7 million NIH grant supports research on why lean people develop insulin resistance

A Wayne State University research team was awarded a $5.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health focused on discovering the biological mechanisms that may help explain why some lean people develop insulin resistance while some people with obesity remain sensitive to insulin.

29 Sep 2026

Maternal depression linked to neurodevelopmental disorders in children

Children of mothers with depression had higher rates of certain neurodevelopmental disorders regardless of whether they were exposed to antidepressants in the womb, reports a new study led by Saraid McIlvride of the University of Glasgow, UK, published September 29th in the open access journal PLOS Medicine.

29 Sep 2026

Antibiotic resistance gene helps C. difficile spores withstand hospital disinfectants

Antibiotic resistance is supercharging dangerous gut bacteria to withstand even hospital-grade disinfectants intended to kill them.

29 Sep 2026

Simulations reveal how changing enzyme shapes affect molecular recognition

Enzymes are often described as molecular machines that recognize and process specific molecules. However, they are not rigid structures. Their shapes can change, and these changes can affect how molecules enter, interact with, and remain within their active sites.

29 Sep 2026

New study uncovers breakthrough window to prevent brain metastasis

Metastasis, the process by which a tumor spreads throughout the body, is associated with the majority of cancer deaths.

29 Sep 2026

New registry data shows semaglutide does not cause pancreatic cancer

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) shows no link between semaglutide use and pancreatic cancer using nationwide registry data from Denmark, Sweden and Norway.

29 Sep 2026

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

HR+/HER2− breast cancer constitutes approximately 65–75% of all breast cancer cases worldwide. Although CDK4/6 inhibitors have substantially extended progression-free survival (PFS), up to 60% of patients derive no clinical benefit from these agents, underscoring the urgent need for more effective therapeutic strategies.

28 Sep 2026

Intentional substance exposures at school rise sharply among younger children

A new study found that rates of intentional substance exposures at school reported to U.S. poison centers increased substantially among elementary- and middle-school-aged children from 2000 through 2024, while high-school-aged adolescents continued to experience the highest rates of serious medical outcomes and hospital admissions.

28 Sep 2026

New antibody treatment blocks immune response to prevent Alzheimer's damage

There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer's disease, in which twisted clumps of a protein called tau accumulate in the brain.

28 Sep 2026

Study finds rising cannabis use disorder among older adults

Cannabis use is becoming increasingly common among older adults in the United States, but less is known about how often cannabis use may become problematic in this population.

28 Sep 2026

Previous
1
...
6
7
8
9
10
11
12
...
3034
Next

Drugs News and Research

GLP-1 receptor agonist exposure shows no link to major adverse pregnancy outcomes

Study examines the real-world use of GLP-1 RA drugs in children and young people

Insurance hurdles and costs hinder access to blood cancer drugs

UC San Diego receives funding to establish the Polysubstance Addiction Research Center

Scientists discover molecular pathway that controls cellular waste recycling

MSU researchers seek to better understand a viral mechanism shared between influenza and HIV

Declining benzodiazepine use reflects more cautious medical prescribing practices

Anti-fibrotic compound alters cell communication by redirecting cellular packages

Streamlining CRISPR workflows, from editing to analysis

Petrelintide produces double-digit weight loss with fewer side effects

$5.7 million NIH grant supports research on why lean people develop insulin resistance

Maternal depression linked to neurodevelopmental disorders in children

Antibiotic resistance gene helps C. difficile spores withstand hospital disinfectants

Simulations reveal how changing enzyme shapes affect molecular recognition

New study uncovers breakthrough window to prevent brain metastasis

New registry data shows semaglutide does not cause pancreatic cancer

Triple combination therapy trial for HR+/HER2− breast cancer halts early due to toxicity concerns

Intentional substance exposures at school rise sharply among younger children

New antibody treatment blocks immune response to prevent Alzheimer's damage

Study finds rising cannabis use disorder among older adults

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News